| Dr Mary F Callahan, MD | |
|
2520 Green Tech Dr, Ste D, State College, PA 16803-2300 | |
| (814) 234-5021 | |
| (814) 235-3313 |
| Full Name | Dr Mary F Callahan |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 2520 Green Tech Dr, State College, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275508194 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD037354E (Pennsylvania) | Primary |
| Entity Name | Geisinger Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366493868 PECOS PAC ID: 5395657001 Enrollment ID: O20040130000518 |
News Archive
Findings from a federally funded study suggest that patients with locally advanced kidney cancer should not be treated with either adjuvant (post-surgery) sorafenib or sunitinib. The average period to disease recurrence was similar between those who received sorafenib or sunitinib after surgery (5.6 years) and those treated with placebo (5.7 years).
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
Sequel Systems, Inc., a dynamic, service-oriented healthcare technology company, today announced the launch and general availability of SequelMed Patient Portal™, a new, Web-based tool that improves and speeds up communication between physicians and patients, giving patients instant access to their personal health information, and allowing physicians and other healthcare providers more time to focus on delivering the best possible care. SequelMed Patient Portal is the latest addition to Sequel Systems' suite of healthcare solutions, which includes an electronic health record (EHR), practice and document management software, and e-prescribing technology. More than 12,000 physicians in all 50 states and representing all major specialties currently use the company's solutions.
A new statistical analysis supports beliefs that COVID-19 became more lethal in the U.K. in late 2020, while also suggesting that multiple factors-;not just the alpha variant of the virus that causes COVID-19-;were to blame.
Benign growth, or cancer? Tumor markers in the blood help determine whether the patient is afflicted with a malign tumor and whether it is excreting markers more vigorously - involving highly specific proteins. An increased concentration in the blood provides one indication of the disease for physicians. However, it has been quite expensive in time and effort to detect the markers thus far. This is because all kinds of molecules and proteins are teeming in the blood. To be able to detect a single specific one, doctors must first separate and purify the blood in several steps, and then isolate the marker they are searching for from the rest of the molecules.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mary F Callahan, MD 100 N Academy Ave, Danville, PA 17822-3034 Ph: (570) 271-6144 | Dr Mary F Callahan, MD 2520 Green Tech Dr, Ste D, State College, PA 16803-2300 Ph: (814) 234-5021 |
News Archive
Findings from a federally funded study suggest that patients with locally advanced kidney cancer should not be treated with either adjuvant (post-surgery) sorafenib or sunitinib. The average period to disease recurrence was similar between those who received sorafenib or sunitinib after surgery (5.6 years) and those treated with placebo (5.7 years).
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
Sequel Systems, Inc., a dynamic, service-oriented healthcare technology company, today announced the launch and general availability of SequelMed Patient Portal™, a new, Web-based tool that improves and speeds up communication between physicians and patients, giving patients instant access to their personal health information, and allowing physicians and other healthcare providers more time to focus on delivering the best possible care. SequelMed Patient Portal is the latest addition to Sequel Systems' suite of healthcare solutions, which includes an electronic health record (EHR), practice and document management software, and e-prescribing technology. More than 12,000 physicians in all 50 states and representing all major specialties currently use the company's solutions.
A new statistical analysis supports beliefs that COVID-19 became more lethal in the U.K. in late 2020, while also suggesting that multiple factors-;not just the alpha variant of the virus that causes COVID-19-;were to blame.
Benign growth, or cancer? Tumor markers in the blood help determine whether the patient is afflicted with a malign tumor and whether it is excreting markers more vigorously - involving highly specific proteins. An increased concentration in the blood provides one indication of the disease for physicians. However, it has been quite expensive in time and effort to detect the markers thus far. This is because all kinds of molecules and proteins are teeming in the blood. To be able to detect a single specific one, doctors must first separate and purify the blood in several steps, and then isolate the marker they are searching for from the rest of the molecules.
› Verified 4 days ago
Dr. Ryan R Ridenour, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1800 E Park Ave, State College, PA 16803 Phone: 814-278-4818 Fax: 814-234-6150 | |
Dr. Wasiq Mateen Ahmad, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1850 E Park Ave Ste 207, State College, PA 16803 Phone: 814-235-2480 | |
Franklin James Berkey, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 476 Rolling Ridge Dr, Suite 101, State College, PA 16801 Phone: 814-689-4980 Fax: 814-689-4990 | |
Stephen Pandolph, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1528 Martin St, Suite 210, State College, PA 16803 Phone: 814-234-4811 | |
Gary Franklin Schell, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 140 W North Hills Pl, State College, PA 16803 Phone: 814-238-8880 Fax: 814-765-8499 | |
Stacy Emile, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1800 E Park Ave, State College, PA 16803 Phone: 814-278-4818 | |
Jesse Julian Miller, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1850 E Park Ave Ste 112, State College, PA 16803 Phone: 800-243-1455 Fax: 814-863-7803 |